Aug 4, 2025 08:00AM
Mar 10, 2025 04:05PM
Feb 11, 2025 08:00AM
Nov 14, 2024 04:01PM
Mar 7, 2024 04:01PM
Feb 13, 2024 08:01AM
Feb 13, 2024 08:00AM Lineage Announces FDA Clearance of IND Amendment for OPC1 Cell Transplant for the Treatment of Spinal Cord Injury
Dec 18, 2023 08:05AM
Dec 18, 2023 08:00AM
Nov 9, 2023 04:01PM
Aug 10, 2023 04:01PM
May 11, 2023 04:01PM
Mar 9, 2023 04:01PM
Feb 8, 2023 08:05AM Lineage Cell Therapeutics (LCTX) Provides Update on Auditory Neuronal Cell Transplant Program for the Treatment of Hearing Loss
Feb 8, 2023 08:00AM
Nov 29, 2022 08:00AM
Nov 28, 2022 08:00AM
Nov 10, 2022 04:05PM
Oct 10, 2022 08:00AM
Aug 11, 2022 04:05PM
May 12, 2022 04:05PM Lineage Cell Therapeutics Reports First Quarter 2022 Financial Results and Provides Business Update
May 3, 2022 08:01AM
May 3, 2022 08:00AM
Apr 13, 2022 08:00AM
Mar 24, 2022 04:27PM
Mar 21, 2022 08:00AM
Mar 14, 2022 08:00AM
Mar 10, 2022 04:05PM Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update
Nov 30, 2021 08:00AM
Nov 15, 2021 08:00AM
Nov 10, 2021 04:05PM
Oct 26, 2021 08:00AM
Sep 30, 2021 10:53AM
Sep 30, 2021 10:52AM
Sep 15, 2021 09:05AM Lineage Cell (LCTX) Announces Data From Clinical Trial Continues to Demonstrate Single Administration of OpRegen Can Provide Anatomical and Functional Improvements in Patients With Dry AMD With Geogra
Sep 15, 2021 09:00AM
Aug 12, 2021 04:05PM
Jul 20, 2021 08:08AM
Jul 20, 2021 08:00AM
Jun 22, 2021 10:45AM
Jun 22, 2021 06:50AM
Jun 3, 2021 08:00AM Lineage Cell Therapeutics to Host Webinar With Therapeutic Area Experts to Discuss Retinal Tissue Restoration Observed in Dry AMD Patients Treated With OpRegen®
May 13, 2021 04:05PM
Apr 12, 2021 08:00AM
Mar 31, 2021 09:22AM
Mar 30, 2021 05:42PM
Mar 23, 2021 08:03AM
Mar 23, 2021 08:00AM
Mar 11, 2021 04:05PM Lineage Cell Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
Feb 16, 2021 08:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All